Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.
Telum Therapeutics has raised $20.5M in total funding. The most recent round was Series A. The last funding was announced in July 2026.
Telum Therapeutics's investors include Inveready, Clave Capital, CDTI Innovación's INNVIERTE program, Invivo Capital Partners, Centre for the Development of Industrial Technology (CDTI).
Telum Therapeutics is headquartered in Noáin, Spain.
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.
Telum Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Telum Therapeutics — Funding & Investors." VCBacked, July 1, 2026, https://www.vcbacked.co/company/telum-therapeutics. Accessed October 29, 2026.
VCBacked. (2026). Telum Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/telum-therapeutics
{{cite web |title=Telum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/telum-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated